dc.contributor.author | Lavelle, Edward | |
dc.date.accessioned | 2021-03-01T18:00:39Z | |
dc.date.available | 2021-03-01T18:00:39Z | |
dc.date.issued | 2020 | |
dc.date.submitted | 2020 | en |
dc.identifier.citation | Lavelle, E.C. and Carsetti, R. and Pickl, W.F. and Wiedermann, U., Editorial: Challenges in Vaccinology, Frontiers in Immunology, 2020, 11, 632537 | en |
dc.identifier.other | Y | |
dc.description.abstract | The COVID19 pandemic has focused minds as rarely before on the vital contribution of vaccines to modern life. In addition to issues related to antigen identification, vaccine adjuvants, vectors and formulations, knowledge is increasing on how a range of factors including age, sex, comorbidities,and the microbiome can impact on responses to vaccines. In this issue, the wide breadth of outstanding issues and opportunities are raised relating to urgent vaccine needs, limitations of current approaches, and the potential of cutting edge technologies to facilitate new advances are highlighted. | en |
dc.language.iso | en | en |
dc.relation.ispartofseries | Frontiers in Immunology; | |
dc.relation.ispartofseries | 11; | |
dc.relation.ispartofseries | 632537; | |
dc.rights | Y | en |
dc.subject | vaccine, systems biology, adjuvant, emerging infectious diseases, nosocomial infections, demographic changes, microbiome | en |
dc.subject.lcsh | vaccine, systems biology, adjuvant, emerging infectious diseases, nosocomial infections, demographic changes, microbiome | en |
dc.title | Editorial: Challenges in Vaccinology | en |
dc.type | Journal Article | en |
dc.type.supercollection | scholarly_publications | en |
dc.type.supercollection | refereed_publications | en |
dc.identifier.peoplefinderurl | http://people.tcd.ie/lavellee | |
dc.identifier.rssinternalid | 224684 | |
dc.identifier.doi | http://dx.doi.org/10.3389/fimmu.2020.632537 | |
dc.rights.ecaccessrights | openAccess | |
dc.identifier.orcid_id | 0000-0002-3167-1080 | |
dc.identifier.uri | http://hdl.handle.net/2262/95452 | |